Healthcare
•3734 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (3734)
| Company | Market Cap | Price |
|---|---|---|
|
VERA
Vera Therapeutics, Inc.
Atacicept is a biologic therapeutic (dual BAFF/APRIL inhibitor) with a monoclonal antibody–like profile, placing Vera's lead program under Monoclonal Antibody Therapeutics.
|
$2.70B |
$42.29
+0.12%
|
|
LFST
LifeStance Health Group, Inc.
Direct provider of behavioral health outpatient services (therapy, psychiatric evaluations, care coordination).
|
$2.68B |
$6.89
+3.37%
|
|
ZLAB
Zai Lab Limited
Core oncology focus across a deep late-stage pipeline including multiple oncology antibodies and ADC assets.
|
$2.68B |
$24.19
+2.94%
|
|
VCYT
Veracyte, Inc.
The company offers MRD and other liquid biopsy tests, placing it in the liquid biopsy space.
|
$2.67B |
$33.79
+2.30%
|
|
ADMA
ADMA Biologics, Inc.
ADMA's core offerings are plasma-derived immunology therapeutics (immunoglobulins) used to treat immune deficiencies and related conditions.
|
$2.62B |
$11.03
+2.70%
|
|
RCUS
Arcus Biosciences, Inc.
Arcus operates in oncology with innovative IO therapies (HIF-2α inhibitor casdatifan; TIGIT antibody domvanalimab; CD73 inhibitor quemliclustat) making it a Biotech - Oncology company.
|
$2.62B |
$24.27
+2.88%
|
|
ALMS
Alumis Inc. Common Stock
Alumis is developing oral TYK2 inhibitors (ESK-001 and A-005), a major product category of oral small molecule therapeutics.
|
$2.61B |
$24.98
-0.08%
|
|
NHC
National HealthCare Corporation
NHC operates integrated healthcare services and facilities, including skilled nursing, home health, hospice, and behavioral health services.
|
$2.61B |
$167.71
+3.96%
|
|
LMAT
LeMaitre Vascular, Inc.
Directly produces vascular interventional devices (grafts, patches, shunts, catheters) used in vascular surgery.
|
$2.59B |
$114.47
+2.53%
|
|
GEO
The GEO Group, Inc.
Provides continuum of care rehabilitation and post-release services as part of corrections/rehabilitation programs.
|
$2.59B |
$18.61
+2.48%
|
|
OGN
Organon & Co.
Directly manufactures/markets medical devices (Nexplanon implant and Jada System) used in women's health and obstetric care.
|
$2.54B |
$9.77
+4.66%
|
|
BBUC
Brookfield Business Corporation
Operates private hospitals and related hospital services.
|
$2.54B |
$34.77
+2.02%
|
|
KN
Knowles Corporation
Knowles has a significant MedTech / medical device presence via advanced microphones and related audio components used in medical devices.
|
$2.53B |
$29.69
+2.38%
|
|
OSW
OneSpaWorld Holdings Limited
Medi-Spa offerings utilize medical devices and biometrics (e.g., CoolSculpting Elite, Elemis Biotec, LightStim).
|
$2.52B |
$24.69
+2.53%
|
|
ACHC
Acadia Healthcare Company, Inc.
ACHC is a pure-play behavioral health provider delivering inpatient and outpatient mental health and substance use treatment services.
|
$2.49B |
$26.99
+0.37%
|
|
MLYS
Mineralys Therapeutics, Inc.
Lorundrostat is an orally administered small-molecule therapeutic targeting aldosterone synthesis for hypertension, classifiable as an Oral Small Molecule Therapeutic.
|
$2.42B |
$30.59
+0.10%
|
|
RARE
Ultragenyx Pharmaceutical Inc.
Ultragenyx is a rare-disease focused biotech company with approved therapies and a pipeline centered on ultra-rare diseases.
|
$2.39B |
$24.83
+1.26%
|
|
AAPG
Ascentage Pharma Group International
Ascentage Pharma is a biotech company focused on oncology, developing apoptosis-targeted cancer therapies (olverembatinib, lisaftoclax, alrizomadlin).
|
$2.39B |
$27.83
+2.47%
|
|
KOD
Kodiak Sciences Inc.
Kodiak is developing ophthalmic drugs (intravitreal biologics) for retinal diseases, making Ophthalmic Drugs a core product category.
|
$2.38B |
$44.89
+11.09%
|
|
BBU
Brookfield Business Partners L.P.
Healthscope operates hospital services, a healthcare services/ facilities business.
|
$2.34B |
$31.53
+0.22%
|
|
BHE
Benchmark Electronics, Inc.
Manufactures Medical Device Components for use in regulated medical devices.
|
$2.32B |
$65.02
+2.72%
|
|
PAHC
Phibro Animal Health Corporation
Vaccines are explicitly listed as a pillar of the Animal Health segment.
|
$2.31B |
$57.04
+5.86%
|
|
CLDX
Celldex Therapeutics, Inc.
Barzolvolimab is a therapeutic monoclonal antibody, placing Celldex in Monoclonal Antibody Therapeutics.
|
$2.30B |
$34.51
+1.90%
|
|
IMNM
Immunome, Inc.
Primary modality across the pipeline is Antibody-Drug Conjugates (ADCs).
|
$2.26B |
$24.62
+5.85%
|
|
SRPT
Sarepta Therapeutics, Inc.
Directly develops gene therapies (ELEVIDYS) and other gene therapy programs; gene therapy is Sarepta's core biotech focus.
|
$2.26B |
$21.54
+1.72%
|
|
XRAY
DENTSPLY SIRONA Inc.
XRAY directly manufactures dental equipment used in clinical practice (imaging, CAD/CAM, etc.), fitting this tag.
|
$2.24B |
$11.29
+0.13%
|
|
MNMD
Mind Medicine (MindMed) Inc.
MindMed's pipeline centers on neuropsychiatric drug development, placing it in the Neuropsychiatric Drug Development investable theme.
|
$2.23B |
$22.66
+3178.61%
|
|
ADPT
Adaptive Biotechnologies Corporation
ADPT directly provides clonoSEQ MRD diagnostic testing and related laboratory services.
|
$2.21B |
$14.49
+2.91%
|
|
DAWN
Day One Biopharmaceuticals, Inc.
Company operates as Biotech - Oncology focusing on cancer therapies (pLGG).
|
$2.20B |
$21.47
+0.09%
|
Showing page 10 of 38 (3734 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
